ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Anixa Biosciences Inc
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$2.61−0.06 (-2.25%)
Close on Oct 19, 2026
- Market cap
- $89.22M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 18, 2015(first seen in filings) | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Jun 26, 2015 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Jun 18, 1996 | 2-for-1 | Earlier per-share figures divided by 2 |
| Mar 19, 1991 | 2-for-1 | Earlier per-share figures divided by 2 |
| Sep 16, 1987 | 5-for-4 | Earlier per-share figures divided by 1.25 |
| Nov 12, 1985 | 3-for-1 | Earlier per-share figures divided by 3 |